<html>
<head>PUBMED IDs for ADAR3</head>
<body bgcolor='#C5F0F2'><h1>ADAR3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10836796/'>A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.</a> June 3  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12618436/'>Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA.</a> March 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15556947/'>ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells.</a> November 24  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17554622/'>Editing of AMPA and serotonin 2C receptors in individual central neurons, controlling wakefulness.</a> June 8  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18178553/'>Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.</a> January 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19472181/'>Origins and evolution of ADAR-mediated RNA editing.</a> September 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19472128/'>Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.</a> August 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19472123/'>CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.</a> August 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21211811/'>Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.</a> May 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21211798/'>Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.</a> June 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21211797/'>Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin.</a> June 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21211790/'>A novel p.S34N mutation of CAMP gene in patients with periodontal disease.</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/28167531/'>Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.</a> February 8  2017<br></body></html>
